THERIVA BIOLOGICS INC
TOVXNYSE AMERICAN🏆 #4488 by market capEarnings Nov 17US Equity
$0.23▲ $0.00 (+1.96%)
Live1h▼ 1.1%
24h▲ 2.0%
7d▲ 2.7%
14d▲ 9.6%
30d▲ 1.9%
1y▼ 43.5%
🏦Market Cap
$11M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
71.5%
High
💵FCF Margin
—
⚖️P/S Ratio
34.7x
Expensive
Otter Score
66
Fair
Earnings
Q3 · 2026Reported 2026-08-11Earnings Per Share
Actual
-0.07
Expected
-0.06
miss
−27.30%
YoY +96.40%
Revenue
Actual
—
Expected
—
—
—
Consensus estimates
Recent quarters
Q3 2026
-0.07
miss
Q2 2026
-0.05
inline
Q1 2026
1.85
beat
Q4 2025
-0.45
miss